Navigation Links
Kids on Medicaid May Face Barriers to Eczema Treatment
Date:5/3/2013

FRIDAY, May 3 (HealthDay News) -- Many Medicaid-insured children with eczema have limited access to dermatologists, a new study finds.

In conducting the study, researchers posed as parents trying to schedule an appointment for their child with eczema. Unlike children with private insurance, Medicaid-insured children often had to provide a written referral or identification numbers before an appointment could be scheduled.

Eczema most often affects children. The condition causes itchy, red, cracked and dry skin. Eczema can also disrupt sleep and negatively affect behavior and quality of life.

"The purpose of this study was to compare access to dermatologists for new pediatric patients with eczema insured by Medicaid versus private plans," study first author Dr. Sofia Chaudhry, an assistant professor of dermatology at Saint Louis University and a practicing dermatologist, said in a school news release.

The researchers said the lack of access to a dermatologist is particularly worrisome since eczema affects 20 percent of children in the United States. Complicating matters, health care reform will expand the number of children insured by Medicaid from about 32 million to roughly 50 million.

"This is a complex problem and a major health disparity in our country," lead study investigator Dr. Elaine Siegfried, a professor of pediatrics at Saint Louis University, said in the news release. "Thirty percent of all children seen in primary care offices have a skin problem. It's an everyday issue."

The study revealed that only 19 percent of all dermatologists in 13 U.S. cities accept Medicaid. Of the nearly 500 specialists who were listed as Medicaid-participating providers by Medicaid insurance plans, 44 percent refused to schedule an appointment with a new Medicaid-insured child.

Chaudhry explained why the situation needs to change.

"Since [eczema] can be a chronic debilitating disease, it's important for these children to be able to see a dermatologist," she said. "Improved access to dermatologists is important for treating eczema in order to enhance the well-being of affected children and to minimize the expensive cost of emergency care."

The researchers suggested possible reasons dermatologists may be reluctant to see Medicaid-insured patients, including:

  • Concerns about additional administrative paperwork
  • Convoluted or delayed payments
  • A high no-show rate of patients
  • Extra time required to address patients with complex social issues
  • Possible medical-legal liabilities associated with these patients

The study was published online and in the May print issue of the Journal of the American Academy of Dermatology.

More information

Visit the U.S. National Institutes of Health to learn more about health disparities.

-- Mary Elizabeth Dallas

SOURCE: Saint Louis University Medical Center, news release, April 29, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Medicaid Expansion Enhances Financial and Mental Well-Being, Study Says
2. Medicaid-insured children have limited access to dermatologists, SLU researchers find
3. Medicaid Fraud in New York Targeted by New House Report
4. Expanding Medicaid in Pennsylvania would increase federal revenue to the state, study finds
5. Antipsychotic Drug Use Rising for Kids on Medicaid, Study Finds
6. ACP, others oppose paying for fiscal cliff by halting Medicaid primary care fee increases
7. New analysis examines stakes for Medicaid in upcoming fiscal cliff negotiations on Capitol Hill
8. Assessing the cost of the Affordable Care Act and expanding Medicaid
9. Health Reform 2.0: Governors Pushing Back on Medicaid Expansion
10. Poorest Americans at risk if states opt out of Medicaid expansion
11. Expanding Medicaid to low-income adults leads to improved health, fewer deaths
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Kids on Medicaid May Face Barriers to Eczema Treatment
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... pleased to announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for ... JMIR Medical Informatics . , Results of the comparative usability study demonstrate ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s ... groups, has aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced ... J. Hennessy, Jr said, “CURE Media Group is honored to team up with Upstage ...
(Date:12/8/2016)... , ... December 08, 2016 , ... Premier Fitness Camp ... FIT , the ultimate weight loss and wellness program, at their world headquarters of ... to provide immediate and long-term results to anyone seeking weight loss, personal development, a ...
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma Solutions, the leading ... consumer health products, today announced that it had joined the Pharmaceutical Supply Chain ... organization to unite pharmaceutical and healthcare companies that share a vision of better, ...
(Date:12/8/2016)... , ... December 08, 2016 , ... California Senate Bill ... payments per workers’ compensation claim in 2013 and 2014, according to CompScope™ Medical ... Institute (WCRI) . , According to the study, medical payments per claim in California ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016   TriNetX ... Nationwide Children,s Hospital signed a membership ... accelerate the development of new cures. ... representing over 57 million patients globally, biopharmaceutical companies ... together to improve protocol design, site selection, patient ...
(Date:12/8/2016)... LAVAL, Quebec , Dec. 8, 2016 /PRNewswire/ ... and TSX: VRX) ("Valeant") today announced positive ... vehicle-controlled clinical study to assess the safety and ... in the treatment of plaque psoriasis. ... adult subjects with moderate to severe psoriasis, IDP-118 ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, LLC ... obtained proof-of-mechanism for neflamapimod (previously code named VX-745), ... 2a clinical trials that demonstrated significant Alzheimer,s disease ... (12-week treatment) and Study 303 (6-week treatment) are ... in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: